| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/03/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 10k | $14.41 | $144.4k | | 10/02/2023 |
| 10/03/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 710 | $15.11 | $10.7k | | 10/02/2023 |
| 10/02/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 9.5k | $15.23 | $144.9k | | 10/02/2023 |
| 05/16/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 15k | $19.98 | $299.7k | | 05/16/2023 |
| 05/15/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 14.8k | $21.06 | $311.7k | | 05/11/2023 |
| 05/15/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 200 | $21.52 | $4.3k | | 05/11/2023 |
| 05/12/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 11.9k | $20.42 | $242.4k | | 05/11/2023 |
| 05/12/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 3.1k | $19.69 | $61.6k | | 05/11/2023 |
| 05/11/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 15k | $20.71 | $310.6k | | 05/11/2023 |
| 03/01/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 70.9k | $0.00 | $0 | | 02/28/2023 |
| 02/28/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 3.1k | $28.00 | $87.2k | | 02/28/2023 |
| 01/23/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 3.7k | $33.64 | $125.5k | | 01/23/2023 |
| 01/05/2023 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 3.8k | $29.26 | $112k | | 01/05/2023 |
| 02/28/2022 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 34.8k | $0.00 | $0 | | 02/28/2022 |
| 04/01/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 16.3k | $41.87 | $681.6k | | 04/01/2021 |
| 04/01/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Exercise | Employee Stock Option (right to buy) | 31.2k | $8.78 | $273.9k | | 04/01/2021 |
| 02/23/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Gift | Common Stock | 16.3k | $0.00 | $0 | | 04/01/2021 |
| 01/23/2021 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 4.6k | $47.70 | $220.9k | | 01/23/2021 |
| 01/23/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Payment of Exercise | Common Stock | 7.5k | $57.98 | $437.6k | | 01/23/2020 |
| 01/05/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 58.3k | $0.00 | $0 | | 01/05/2020 |
| 01/05/2020 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Employee Stock Option (right to buy) | 145.7k | $59.80 | $8.7M | | 01/05/2020 |
| 12/31/2019 | Alaunos Therapeutics, Inc. | ZIOP | Grant | Stock Option (right to buy) | 50.6k | $4.72 | $238.7k | | 12/31/2019 |
| 12/04/2019 | Theriva Biologics, Inc. | SYN | Grant | Stock Options | 250k | $0.42 | $104.5k | | 12/04/2019 |
| 04/01/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Commn Stock | 25k | $50.15 | $1.3M | | 04/01/2019 |
| 03/01/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 12k | $50.51 | $606.1k | | 03/01/2019 |
| 03/01/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 12.4k | $51.81 | $643.9k | | 03/01/2019 |
| 02/01/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 29.2k | $41.52 | $1.2M | | 02/01/2019 |
| 02/01/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 900 | $42.30 | $38.1k | | 02/01/2019 |
| 01/23/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Common Stock | 61.3k | $0.00 | $0 | | 01/23/2019 |
| 01/23/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Grant | Employee Stock Option (right to buy) | 137.2k | $42.40 | $5.8M | | 01/23/2019 |
| 01/03/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 10.6k | $39.04 | $413.7k | | 01/02/2019 |
| 01/03/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 5.7k | $39.70 | $225.1k | | 01/02/2019 |
| 01/03/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 302 | $40.57 | $12.3k | | 01/02/2019 |
| 01/02/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 6.5k | $39.30 | $255.4k | | 01/02/2019 |
| 01/02/2019 | EAGLE PHARMACEUTICALS, INC. | EGRX | Sale | Common Stock | 8.5k | $40.03 | $340.3k | | 01/02/2019 |
|